Birger Johnsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Birger Johnsen has a total of 240 co-authors. Here are the top co-authors by number of shared publications:
- Anders Fuglsang-Frederiksen
Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark
37 shared publications - Kirsten Pugdahl
Department of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark
17 shared publications - Rocco Liguori
Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy
16 shared publications - Nanna Brix Finnerup
Department of Clinical Medicine, Danish Pain Research Center Aarhus University Aarhus Denmark
10 shared publications Hatice Tankisi
Department of Clinical Neurophysiology Aarhus University Hospital Aarhus Denmark
8 shared publicationsW. Nix
Department of Neurology, University Clinics Mainz, Mainz, Germany
7 shared publications
Latest Publications
- Open Access
- 7 March 2025
- Published by Elsevier in Clinical Neurophysiology Practice
- Vol. 10, 79-83
Electrodiagnostic criteria for neuromuscular transmission disorders suggested by a European consensus group
- 7 March 2025
- Published by Elsevier in Clinical Neurophysiology Practice
- Vol. 10, 79-83
Open AccessElectrodiagnostic criteria for neuromuscular transmission disorders suggested by a European consensus group
- Open Access
- 17 July 2024
- Published by Elsevier in Resuscitation
- Vol. 202, 110319
EEG for good outcome prediction after cardiac arrest: A multicentre cohort study
- 17 July 2024
- Published by Elsevier in Resuscitation
- Vol. 202, 110319
Open AccessEEG for good outcome prediction after cardiac arrest: A multicentre cohort study
- Open Access
- 10 February 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (2) , 209
EEG Frequency Correlates with α2-Receptor Density in Parkinson’s Disease
Introduction: Increased theta and delta power and decreased alpha and beta power, measured with quantitative electroencephalography (EEG), have been demonstrated to have utility for predicting the development of dementia in patients with Parkinson’s disease (PD). Noradrenaline modulates cortical activity and optimizes cognitive processes. We claim that the loss of noradrenaline may explain cognitive impairment and the pathological slowing of EEG waves. Here, we test the relationship between the number of noradrenergic α2 adrenoceptors and changes in the spectral EEG ratio in patients with PD. Methods: We included nineteen patients with PD and thirteen healthy control (HC) subjects in the study. We used positron emission tomography (PET) with [11C]yohimbine to quantify α2 adrenoceptor density. We used EEG power in the delta (δ, 1.5–3.9 Hz), theta (θ, 4–7.9 Hz), alpha (α, 8–12.9 Hz) and beta (β, 13–30 Hz) bands in regression analyses to test the relationships between α2 adrenoceptor density and EEG band power. Results: PD patients had higher power in the theta and delta bands compared to the HC volunteers. Patients’ theta band power was inversely correlated with α2 adrenoceptor density in the frontal cortex. In the HC subjects, age was correlated with, and occipital background rhythm frequency (BRF) was inversely correlated with, α2 adrenoceptor density in the frontal cortex, while occipital BRF was inversely correlated with α2 adrenoceptor density in the thalamus. Conclusions: The findings support the claim that the loss or dysfunction of noradrenergic neurotransmission may relate to the parallel processes of cognitive decline and EEG slowing.
- 10 February 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (2) , 209
Open AccessEEG Frequency Correlates with α2-Receptor Density in Parkinson’s Disease
Introduction: Increased theta and delta power and decreased alpha and beta power, measured with quantitative electroencephalography (EEG), have been demonstrated to have utility for predicting the development of dementia in patients with Parkinson’s disease (PD). Noradrenaline modulates cortical activity and optimizes cognitive processes. We claim that the loss of noradrenaline may explain cognitive impairment and the pathological slowing of EEG waves. Here, we test the relationship between the number of noradrenergic α2 adrenoceptors and changes in the spectral EEG ratio in patients with PD. Methods: We included nineteen patients with PD and thirteen healthy control (HC) subjects in the study. We used positron emission tomography (PET) with [11C]yohimbine to quantify α2 adrenoceptor density. We used EEG power in the delta (δ, 1.5–3.9 Hz), theta (θ, 4–7.9 Hz), alpha (α, 8–12.9 Hz) and beta (β, 13–30 Hz) bands in regression analyses to test the relationships between α2 adrenoceptor density and EEG band power. Results: PD patients had higher power in the theta and delta bands compared to the HC volunteers. Patients’ theta band power was inversely correlated with α2 adrenoceptor density in the frontal cortex. In the HC subjects, age was correlated with, and occipital background rhythm frequency (BRF) was inversely correlated with, α2 adrenoceptor density in the frontal cortex, while occipital BRF was inversely correlated with α2 adrenoceptor density in the thalamus. Conclusions: The findings support the claim that the loss or dysfunction of noradrenergic neurotransmission may relate to the parallel processes of cognitive decline and EEG slowing.
- Open Access
- 12 August 2022
- Published by Elsevier in Clinical Neurophysiology
- Vol. 142, 143-153
Common patterns of EEG reactivity in post-anoxic coma identified by quantitative analyses
- 12 August 2022
- Published by Elsevier in Clinical Neurophysiology
- Vol. 142, 143-153
Open AccessCommon patterns of EEG reactivity in post-anoxic coma identified by quantitative analyses
- Open Access
- 1 December 2021
- Published by Elsevier in Clinical Neurophysiology
- Vol. 132 (12) , 3183-3189
Gold Coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis
- 1 December 2021
- Published by Elsevier in Clinical Neurophysiology
- Vol. 132 (12) , 3183-3189
Open AccessGold Coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis
- 1 September 2021
- Published by Elsevier in Clinical Neurophysiology
- Vol. 132 (9) , 2075-2082
Automatic continuous EEG signal analysis for diagnosis of delirium in patients with sepsis
- 1 September 2021
- Published by Elsevier in Clinical Neurophysiology
- Vol. 132 (9) , 2075-2082
Automatic continuous EEG signal analysis for diagnosis of delirium in patients with sepsis
- Open Access
- 1 January 2021
- Published by Elsevier in Clinical Neurophysiology Practice
- Vol. 6, 72-80
Neuromuscular ultrasound of the scapular stabilisers in healthy subjects
- 1 January 2021
- Published by Elsevier in Clinical Neurophysiology Practice
- Vol. 6, 72-80
Open AccessNeuromuscular ultrasound of the scapular stabilisers in healthy subjects
- 1 August 2020
- Published by Elsevier in Clinical Neurophysiology
- Vol. 131 (8) , 1962-1963
Diagnostic criteria for amyotrophic lateral sclerosis from El Escorial to Gold Coast
- 1 August 2020
- Published by Elsevier in Clinical Neurophysiology
- Vol. 131 (8) , 1962-1963
Diagnostic criteria for amyotrophic lateral sclerosis from El Escorial to Gold Coast
- 9 June 2020
- Published by Springer Nature
- p. 327-329
Clinical Neurophysiology: Continuous EEG Monitoring
- 9 June 2020
- Published by Springer Nature
- p. 327-329
Clinical Neurophysiology: Continuous EEG Monitoring
- 9 June 2020
- Published by Springer Nature
- p. 323-326
Clinical Neurophysiology: Evoked Potentials